Updates

  • Happier January - Week 4

    • Day 22 - Plan something fun and invite others to join you
    • Day 23 - Put away digital devices periodically and focus on being in the moment
    • Day 24 - Take a small step towards an important goal
    • Day 25 - Decide to lift people up rather than put them down
    • Day 26 - Choose one of your strengths and find a way to use it today
    • Day 27 - Challenge your negative thoughts and look for the upside
    • Day 28 - Ask other people about things they've enjoyed recently
    • Day 29 - Say hello to a fellow UTMB employee from a different area and get to know them better
    • Day 30 - See how many people you can smile at today
    • Day 31 - Write down your hopes or plans for the future
  • Happier January - Week 3

    • Day 15 - Get outside and notice five things that are beautiful
    • Day 16 - Contribute positively to your work environment
    • Day 17 - Be gentle with yourself when you make mistakes
    • Day 18 - Get back in contact with an old friend
    • Day 19 - Focus on what’s good, even if today feels tough
    • Day 20 - Go to bed in good time and allow yourself to recharge
    • Day 21 - Try out something new to get out of your comfort zone
  • ¿Que debes hacer?

    Sabemos que nuestros pacientes y comunidades tienen muchas preguntas sobre la variante ómicron del COVID-19. El aumento actual en el número de personas que han dado positivo, incluso entre nuestros propios empleados, ha creado algunos retos.

    Mientras que ómicron parece ser menos letal y peligroso que las versiones anteriores del virus del COVID, es más contagioso y ha causado un alto número de infecciones y personas enfermas o preocupadas.

    Nuestras clínicas y centros de llamadas están recibiendo un increíblemente alto volumen de mensajes y llamadas, en un momento en el que hay escasez de empleados. Es posible que haya una demora en el tiempo de respuesta. Le pedimos disculpas por las demoras y agradecemos su comprensión. Seguimos trabajando para incrementar nuestra capacidad y responder a las necesidades de nuestros pacientes.

    Tengo síntomas y creo que es COVID. ¿Necesito hacerme la prueba?

    Si tiene síntomas, debe hacerse la prueba. UTMB tiene muchos lugares a los que puede acudir para hacérsela, además de otros lugares administrados por el condado, el estado y otros proveedores de atención médica.También puede comprar una prueba que se hace en casa (a menudo llamada prueba de antígeno) si hay disponibles en el área donde vive. Los Centros para el Control y la Prevención de Enfermedades (CDC) han publicado información sobre las pruebas que se realizan en casa.

    Por favor, no vaya a la sala de emergencias para que le hagan la prueba del COVID-19.

    Seguimos ofreciendo pruebas en nuestras clínicas de atención urgente (que tienen un horario prolongado) y en los lugares que ofrecen atención primaria. Necesita cita para hacerse la prueba en UTMB. Programe en línea la cita para la prueba del COVID.

    Tuve contacto cercano con alguien que tiene COVID. ¿Qué significa esto?

    “Contacto cercano” se refiere a la cantidad de tiempo que pasó directamente con una persona infectada, es decir, estuvo dentro de 6 pies de la persona por un total de 15 minutos o más en un periodo de 24 horas. Si ha tenido contacto cercano con una persona infectada, usted corre riesgo de infección sin importar su estatus de vacunación y debe tomar precauciones (como usar una mascarilla y mantener el distanciamiento social). Hágase la prueba si empieza a tener síntomas (y está completamente vacunado), si no se ha vacunado o si está en una categoría de alto riesgo sin importar los síntomas.

    Soy empleado o estudiante de UTMB y es posible que haya estado expuesto al COVID o tenga síntomas del COVID. ¿Qué debo hacer?

    Debido al papel que tenemos de mantener y cuidar la salud de la comunidad, hemos preparado unas pautas y protocolos detallados para el personal clínico y en capacitación, los empleados no clínicos y estudiantes de UTMB. Favor de repasar estas pautas sobre los requisitos relacionados con las pruebas, aislamiento, uso de mascarillas, regreso al trabajo o a la escuela y más en las páginas web sobre el COVID para empleados y estudiantes.

    Estuve expuesto y la prueba dio negativo. ¿Qué debo hacer?

    Si se hizo la prueba en casa y dio negativo, siga las pautas actuales de los CDC relacionadas con la cuarentena y las otras pruebas. Si empieza a tener síntomas, debe hacerse la prueba nuevamente. Si la prueba de antígenos que se hizo en casa da negativo y tiene síntomas, los expertos en salud pública recomiendan hacerse una prueba PCR u otra prueba en casa después de unos días.

    La prueba que me hice en casa dio positivo. ¿Necesito hacerme una prueba PCR?

    Si la prueba que usó en casa dio positivo, tiene COVID-19. No necesita confirmarlo con la prueba PCR. Aíslese en casa inmediatamente y notifique a todas las personas con quienes tuvo contacto cercano del resultado positivo para que puedan tomar las precauciones necesarias.

    ¿Corro alto riesgo de presentar COVID-19 grave?

    Las personas que corren alto riesgo de que se les agrave el COVID-19 incluyen las que reciben tratamiento para el cáncer y las que toman medicamento para un trasplante o medicamentos inmunosupresores para otros padecimientos. Otras condiciones de salud que tal vez causen una predisposición a peores síntomas del COVID-19 o la influenza incluyen enfermedad del pulmón, riñón o del hígado crónica; diabetes; VIH; obesidad o el tener 65 años o más. Los CDC tienen más información en línea sobre condiciones de alto riesgo.

    La prueba dio positivo y no corro alto riesgo de enfermedad grave. Me preocupan mis síntomas. ¿Qué debo hacer?

    Síntomas leves - quédese en casa y aíslese

    Los síntomas leves son una temperatura menor que 100.4 grados (menor que 102.4 grados para niños mayores de 3 meses), dolores musculares o una tos leve. Si tiene estos síntomas, quédese en casa alejado de los demás. Descanse, tome suficientes líquidos y esté pendiente de sus síntomas. Se espera que empiece a sentirse mejor dentro de unos días. No tiene que comunicarse con su médico para informarle que tiene COVID.

    Síntomas moderados - llame a su proveedor de atención médica de UTMB

    Si tiene síntomas moderados como una fiebre mayor que 100.4 grados, bastante tos o dificultad para respirar, comuníquese con el consultorio de su médico de cabecera, una clínica de atención urgente de UTMB o con el Centro de Acceso de UTMB.

    Para niños de 3 meses y mayores que no son inmunocomprometidos, se considera que una fiebre es elevada si es mayor que 102.4 grados. Si su hijo tiene fiebre, bastante tos o dificultad para respirar, debe llamar al consultorio de su médico de cabecera. También debe llamar si tiene más sueño de lo normal, si no ha orinado en más de 10 horas (si tiene 3 años o más) o en más de 8 horas (si tiene menos de 3 años). El médico de su hijo le recomendará los siguientes pasos que debe tomar.

    Síntomas graves - emergencia

    Vaya a la sala de emergencias más cercana (aquí hay una lista de las salas de emergencia de UTMB) si tiene síntomas graves como:

    • Mucha dificultad para respirar
    • Dolor o presión persistente en el pecho
    • Nueva confusión o mareos
    • Inhabilidad de despertarse o quedarse despierto
    • La piel, los labios o las uñas se ven pálidos, grisáceos o azulados, dependiendo del tono de la piel.

    Si no puede ir a la sala de emergencias, llame al 9-1-1.

    La prueba dio positivo y corro alto riesgo de enfermedad grave. Me preocupan mis síntomas. ¿Qué debo hacer?

    Llame al consultorio de su médico de cabecera

    Quizá cumpla los requisitos para recibir tratamiento para el COVID como paciente ambulatorio. Debido a que tenemos suministros limitados de estas terapias, se reservan para los que corren el mayor riesgo.

    Por ejemplo, la terapia de anticuerpos monoclonales (mAB) puede ayudar a luchar contra la infección. Usted cumple los requisitos si corre alto riesgo de presentar COVID-19 grave, tiene una prueba que dio positivo con verificación de un laboratorio y los síntomas empezaron hace 2-8 días.

    Leer más sobre los tratamientos y terapias contra el COVID que ofrece UTMB.

    Además, la Administración de Alimentos y Medicamentos de EE. UU. (FDA, en inglés) ha emitido autorizaciones de uso de emergencia para Paxlovid de Pfizer (tabletas de nirmatrelvir y ritonavir) y Molnupiravir de Merck. Estas son pastillas que se pueden usar para tratar el COVID-19 leve a moderado. Paxlovid está disponible para adultos y niños de 12 años y mayores que pesan por lo menos 88 libras (40 kilogramos). Molnupiravir es para adultos solamente. Ambos están disponibles solo con receta médica para los pacientes que corren alto riesgo de presentar COVID-19 grave. Ambos se deben comenzar lo más pronto posible después del diagnóstico del COVID-19 y dentro de cinco días del comienzo de síntomas. Las farmacias de Walmart participantes en esta área quizá tengan el medicamento. Para más información vaya a la página de Walmart Pharmacy COVID e ingrese su código postal para ver la disponibilidad.

    Recuerde que la influenza se propaga en la comunidad ahora también. Si la prueba del COVID dio negativo pero tiene síntomas moderados, entre ellos fiebre y dolores musculares, comuníquese con su médico de cabecera. Es posible que le haga la prueba de la influenza o que le dé medicamento para esta, especialmente si usted está en uno de los grupos de alto riesgo mencionados arriba.

    Por favor, ayúdenos a ayudarle. Se ha demostrado que las vacunas son eficaces para reducir la gravedad del COVID y para ayudar a las personas a evitar la hospitalización. Si no se ha vacunado, programe ahora la vacuna o la dosis de refuerzo. Use mascarilla cuando esté adentro y evite lugares con mucha gente o mala ventilación. Mantenga el distanciamiento social (6 pies), tápese la boca al toser y lávese las manos con frecuencia.

    Le deseamos la mejor salud y publicaremos información adicional cuando esté disponible.

    Atentamente

    Grupo de Trabajo de Clínicos sobre el COVID-19 en UTMB Health

  • Dosis de refuerzo de Pfizer-BioNTech ahora disponible para 12 años y mas

    El 3 de enero de 2022, la Administración de Alimentos y Medicamentos (FDA, en inglés) enmendó la autorización de uso de emergencia (EUA, en inglés) de la vacuna antiCOVID-19 de Pfizer-BioNTech para expandir el uso de una sola dosis de refuerzo en adolescentes entre 12 y 15 años de edad. El 5 de enero, los Centros para el Control y la Prevención de Enfermedades (CDC, en inglés) también actualizaron sus recomendaciones relacionadas.

    La autorización actualizada también reduce el tiempo entre la primera serie vacunas de Pfizer-BioNTech y la dosis de refuerzo a por lo menos cinco meses y permite una tercera dosis de la serie principal para algunos niños inmunocomprometidos entre 5 y 11 años de edad.

    Estas recomendaciones actualizadas solo son relevantes para la vacuna de Pfizer-BioNTech, no incluyen las vacunas de Moderna ni Johnson & Johnson/Janssen. Las personas de 18 años o mayores que se pusieron la vacuna antiCOVID de Moderna cumplen con los requisitos para recibir una dosis de refuerzo por lo menos seis meses después de haberse puesto la primera serie de vacunas. A las personas que se pusieron la dosis única de la vacuna de Johnson & Johnson/Janssen se les recomienda una dosis de refuerzo si se vacunaron por lo menos hace dos meses.

    Tanto la primera y segunda dosis de la serie de vacunas como la dosis de refuerzo están disponibles con cita en UTMB. Haga la cita para la vacuna antiCOVID en línea en https://www.utmb.edu/covid-19/patients#vaccine.

    Do I qualify for a COVID-19 Vaccine booster and which one? chart

    Hay información adicional disponible en línea sobre la Autorización para el Uso de Emergencia en:

    Ahora que la variante Omicron sigue en aumento en las comunidades que atendemos, es especialmente importante ponerse la dosis de refuerzo cuando se recomienda para aumentar la protección contra la enfermedad grave. Gracias por sus esfuerzos por reducir la propagación del COVID-19.

    Dr. Janak Patel, MD
    Director, Control de Infecciones y Epidemiología en la Atención Médica Profesor, Pediatría y Enfermedades Infecciosas

    Dr. Philip Keiser, MD
    Profesor, Medicina Interna y Enfermedades Infecciosas Autoridad de Salud del Condado de Galveston Presidente del Grupo de Trabajo de UTMB para Vacunación contra el COVID-19

    La Oficina de Mercadotecnia y Comunicaciones del Grupo de Trabajo para Vacunación contra el COVID-19 envió este mensaje.

  • La vacuna antiCOVID-19 de Pfizer-BioNTech ahora está disponible para los niños de 5 a 11 años

    El 29 de octubre, la Administración de Alimentos y Medicamentos (FDA) autorizó el uso de emergencia de la vacuna antiCOVID-19 de Pfizer-BioNTech para la prevención del COVID-19 en niños de entre 5 y 11 años de edad. El 2 de noviembre, los Centros para el Control y la Prevención de Enfermedades (CDC) emitieron la recomendación de que todos los niños de entre 5 y 11 años, sin importar los factores de riesgo, reciban la vacuna pediátrica contra el COVID-19 de Pfizer-BioNTech.

    A partir del 4 de noviembre, todos los centros o consultorios médicos de UTMB que atienden a niños, clínicas pediátricas, clínicas de medicina familiar o centros de atención urgente, empezarán a ofrecer la vacuna, una serie de dos dosis con al menos tres semanas de separación. Se puede administrar la vacuna durante consultas de vacunación pediátricas de rutina o se puede programar una cita en línea en: https://www.utmb.edu/covid-19/spanish/vacuna/COVID19-vacunas-de-dos-dosis.

    La vacuna pediátrica contiene una tercera parte de la cantidad que se encuentra en la de adultos. Se otorgará un periodo de gracia de cuatro días antes y después del cumpleaños de un niño que va a cumplir 12 años para determinar cuál dosis debe recibir. Los niños que tengan 11 años cuando se pongan la primera vacuna deben recibir otra dosis pediátrica de 10 microgramos, aunque cumplan los 12 años cuando les toque la segunda dosis.

    Las investigaciones clínicas pediátricas mostraron que la vacuna tiene una eficacia de casi un 91% en la prevención del COVID-19 en los niños de entre 5 y 11 años, similar a la eficacia que se observó en las investigaciones con adultos. En las investigaciones clínicas pediátricas, los efectos secundarios se limitaron solos y fueron leves y similares a los que se observaron en adultos y a los efectos secundarios de otras vacunas que se recomiendan para los niños. El efecto secundario más común fue dolor del brazo.

    La nueva recomendación de los CDC amplía el acceso a la vacuna antiCOVID-19 a casi 28 millones de niños a lo largo de Estados Unidos que tienen esta edad, lo que marca un paso importante hacia adelante en la lucha contra el virus en el país. Vacunar a los niños ayudará a protegerlos de contraer el COVID-19 y por lo tanto reducirá el riesgo de enfermedad grave, hospitalización y presentación de complicaciones de COVID-19 prolongado. La vacunación también puede ayudar a disminuir las interrupciones al aprendizaje en persona y actividades ya que ayuda a disminuir el contagio en la comunidad.

    Información adicional sobre la vacuna pediátrica:

    • Para vacunar a un niño de esta edad, será necesario que uno de los padres o tutores firme un consentimiento escrito. Si el padre o tutor ha firmado un consentimiento escrito en los últimos 12 meses y está archivado en UTMB, no tendrá que estar presente para que el niño sea vacunado.
    • Todas las vacunas antiCOVID-19 se pueden administrar al mismo tiempo que otras vacunas, incluso la de la influenza, sin tener que esperar entre una y otra.
    • Por favor, piense en inscribirse en V-safe, la herramienta de los CDC que le permite a una persona dar información sobre cómo se siente después de recibir la vacuna.

    Descargar la Hoja informativa para receptores y cuidadores

  • Happier January - Week 2

    • Day 8 - Say positive things to the people you meet today
    • Day 9 - Get moving. Do something active (ideally outdoors even if just for 10 minutes)
    • Day 10 - Thank someone you're grateful to and tell them why
    • Day 11 - Switch off all your tech at least an hour before bedtime
    • Day 12 - Connect with someone near you - share a smile or chat
    • Day 13 - Take a different route today and see what you notice
    • Day 14 - Eat healthy food which really nourishes you today
  • What should you do?

    We know there are many questions among our patients and in our communities about the Omicron variant of COVID-19. The current surge of people who are testing positive – including among our own employees, has created some challenges.

    While Omicron has proven less lethal and dangerous than earlier versions of the COVID virus, it is more contagious, causing high numbers of infections and sick or concerned individuals.

    Our clinics and call centers are receiving an incredibly high volume of messages and calls, at a time when we are experiencing staffing shortages. Response times may be delayed. We apologize for the delays, appreciate your understanding, and continue to work to increase capacity and respond to the needs of our patients.

    I have symptoms that I think might be COVID. Do I need a test?

    If you have symptoms, you should get tested. There are many testing venues offered by UTMB, by county and state health partners, and by other care providers. You can also use a home testing kit (often called antigen tests), if locally available. The Centers for Disease Control and Prevention (CDC) has posted information about home testing.

    Please do not visit our emergency rooms to get a COVID-19 test.

    We continue to offer testing from our urgent care clinics (which offer extended hours) and primary care sites. All testing at UTMB is by appointment. Schedule your COVID test online.

    I have been in close contact with someone who has COVID. What does this mean?

    “Close contact” refers to time you spent directly with an infected person. This means you were within 6 feet of an infected person for a total of 15 minutes or more within a 24-hour period. If you have been in close contact with an infected person, you are at risk of infection regardless of vaccination status and should take precautions (such as masking and social distancing). Get tested if you develop symptoms (fully vaccinated), and/or if you are unvaccinated or in high-risk category, regardless of symptoms.

    I am a UTMB employee or student and may have COVID symptoms or exposure. What should I do?

    Because of the role we play in maintaining and addressing the health of the community, we’ve prepared some detailed guidelines and protocols for our UTMB healthcare workforce and trainees, as well as for non-clinical employees and students. Please review these guidelines on testing requirements, isolation, masking, returning to work/school and more on our employee and student focused COVID web pages.

    I tested negative after an exposure. What should I do?

    If you tested negative with a home test, follow the current CDC guidelines related to quarantine and other testing. If you develop symptoms, you should test again. If a home antigen test is negative and you have symptoms, public health experts recommend getting a PCR test or testing yourself again with a home test after a few days.

    I tested positive at home. Do I need to get a PCR test?

    If you use a home testing kit and test positive, you have COVID-19. You do not need a PCR test for confirmation. Please start home isolation immediately and notify your close contacts of your positive test so they may take the appropriate precautions.

    Am I at high risk for severe COVID-19?

    High-risk conditions for severe COVID-19 include undergoing treatment for cancer, currently taking medications for transplant, or taking immunosuppressant medications for other conditions. Other high-risk conditions, including having chronic lung, kidney, or liver disease; diabetes; HIV; obesity; and age 65 years or older, may pre-dispose you to worse symptoms from COVID-19 or influenza. The CDC has more information about high risk conditions online.

    I tested positive. I’m not at high risk for severe disease. I’m worried about my symptoms. What should I do?

    Mild Symptoms – Stay home and isolate

    Mild symptoms are a temperature below 100.4 degrees (below 102.4 degrees for children older than 3 months), aches and pains, or a mild cough. If you have these symptoms, stay at home and isolate. Rest, drink plenty of fluids, and monitor your symptoms. Hopefully you will start feeling better within a few days. You do not need to contact your doctor to let them know you have COVID.

    Moderate Symptoms – Call Your UTMB Health Care Provider

    If you have moderate symptoms like a fever higher than 100.4 degrees, significant coughing, or shortness of breath, contact your primary care provider’s office, a UTMB Urgent Care clinic, or our UTMB Access Center.

    For children ages 3 months and older who are not immunocompromised, a high fever is greater than 102.4 degrees. If your child has a fever, significant coughing or shortness of breath, you should call their primary care provider’s office. You should also call if they are sleepier, if they have not gone to the bathroom in more than 10 hours (if 3 years or older) or more than 8 hours (if younger than 3 years old). Your child’s doctor can recommend next steps.

    Severe Symptoms – Emergency

    Go to your nearest emergency department (here are UTMB’s Emergency Departments) if you have severe symptoms such as:

    • Severe trouble breathing
    • Persistent pain or pressure in the chest
    • New confusion or dizziness
    • Inability to wake or stay awake
    • Pale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone

    If you cannot get to an emergency department, call 9-1-1.

    I tested positive and I’m at high risk for severe disease. I am worried about my symptoms. What should I do?

    Call your primary care provider’s office

    You may be eligible for outpatient COVID treatment. Because we have limited supplies of these therapies, they are being reserved for those at greatest risk.

    For example, monoclonal antibody therapy (mAB), can help fight the infection. You are eligible if you are at high risk for severe COVID-19, have a positive lab-verified COVID test and are within 2-8 days of starting symptoms.

    Read more about UTMB COVID treatment and therapies.

    Also, the U.S. Food and Drug Administration has issued emergency use authorizations (EUAs) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets) and Merck’s molnupiravir. These are pills that can be used to treat mild-to-moderate COVID-19. Paxlovid is available for adults and children 12 years of age and older weighing at least 40 kilograms/88 pounds. Molnupiravir is for adults only. Both are available by prescription only for patients who are at high risk for severe COVID-19. Both should be started as soon as possible after the diagnosis of COVID-19 and within five days of the start of symptoms. Participating Walmart pharmacies may have the medications in the area. Learn more on the Walmart Pharmacy COVID page and check your ZIP code for availability.

    Please note that the flu is now spreading in our community too. If you have a negative COVID test but have moderate symptoms, including fever and body aches, contact your primary care provider’s office. They may test you for the flu or give you a medication for the flu, especially if you are in one of the high-risk groups listed above.

    Please help us help you. Vaccines have proven to be effective in reducing the severity of COVID and helping avoid hospitalization. If you’ve not been vaccinated, schedule your vaccine and booster now. Wear a mask indoors, and avoid crowded or poorly ventilated places. Practice social distancing (6 ft), cover your cough, and wash your hands frequently.

    We wish you the best of health and will post additional updates as they become available.

    Sincerely,

    The UTMB Health Covid-19 Clinical Task Force

  • Dosis de refuerzo de Pfizer-BioNTech ahora disponible para menores entre 12 y 15 años

    El 3 de enero de 2022, la Administración de Alimentos y Medicamentos (FDA, en inglés) enmendó la autorización de uso de emergencia (EUA, en inglés) de la vacuna antiCOVID-19 de Pfizer-BioNTech para expandir el uso de una sola dosis de refuerzo en adolescentes entre 12 y 15 años de edad. El 5 de enero, los Centros para el Control y la Prevención de Enfermedades (CDC, en inglés) también actualizaron sus recomendaciones relacionadas.

    La autorización actualizada también reduce el tiempo entre la primera serie vacunas de Pfizer-BioNTech y la dosis de refuerzo a por lo menos cinco meses y permite una tercera dosis de la serie principal para algunos niños inmunocomprometidos entre 5 y 11 años de edad.

    Estas recomendaciones actualizadas solo son relevantes para la vacuna de Pfizer-BioNTech, no incluyen las vacunas de Moderna ni Johnson & Johnson/Janssen. Las personas de 18 años o mayores que se pusieron la vacuna antiCOVID de Moderna cumplen con los requisitos para recibir una dosis de refuerzo por lo menos seis meses después de haberse puesto la primera serie de vacunas. A las personas que se pusieron la dosis única de la vacuna de Johnson & Johnson/Janssen se les recomienda una dosis de refuerzo si se vacunaron por lo menos hace dos meses.

    Tanto la primera y segunda dosis de la serie de vacunas como la dosis de refuerzo están disponibles con cita en UTMB. Haga la cita para la vacuna antiCOVID en línea en https://www.utmb.edu/covid-19/patients#vaccine.

    Do I qualify for a COVID-19 Vaccine booster and which one? chart

    Hay información adicional disponible en línea sobre la Autorización para el Uso de Emergencia en:

    Ahora que la variante Omicron sigue en aumento en las comunidades que atendemos, es especialmente importante ponerse la dosis de refuerzo cuando se recomienda para aumentar la protección contra la enfermedad grave. Gracias por sus esfuerzos por reducir la propagación del COVID-19.

    Dr. Janak Patel, MD
    Director, Control de Infecciones y Epidemiología en la Atención Médica Profesor, Pediatría y Enfermedades Infecciosas

    Dr. Philip Keiser, MD
    Profesor, Medicina Interna y Enfermedades Infecciosas Autoridad de Salud del Condado de Galveston Presidente del Grupo de Trabajo de UTMB para Vacunación contra el COVID-19

    La Oficina de Mercadotecnia y Comunicaciones del Grupo de Trabajo para Vacunación contra el COVID-19 envió este mensaje.

  • Pfizer-BioNTech Boosters Now Available for 12+

    On Jan. 3, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to expand the use of a single booster dose to adolescents aged 12 through 15 years old. The Centers for Disease Control and Prevention (CDC) also updated their related recommendations on Jan. 5.

    The updated EUA also shortens the time between the completion of the Pfizer-BioNTech primary series and the booster dose to at least five months and allows for a third primary series dose for certain immunocompromised children aged 5 through 11 years old.

    This updated guidance only applies to the Pfizer-BioNTech vaccine and not the Moderna or Johnson & Johnson/Janssen vaccines. Adults 18 and older who received a Moderna vaccine are eligible for a booster shot at least six months after the completion of their primary series. For individuals who received the Johnson & Johnson/Janssen vaccine, a booster is recommended for everyone who was vaccinated at least two months ago.

    First and second doses and booster shots are available from UTMB by appointment. Schedule your COVID vaccine online.

    Do I qualify for a COVID-19 Vaccine booster and which one? chart

    Additional information on the Emergency Use Authorizations for each vaccine are available online:

    As the Omicron variant continues to surge in the communities we serve, it is especially important to get a booster dose at the recommended time to increase protection against serious illness. Thank you for your efforts to slow the spread of COVID-19.

    Janak Patel, MD Director, Infection Control and Healthcare Epidemiology Professor, Pediatrics/Infectious Disease

    Philip Keiser, MD Professor, Internal Medicine/Infectious Diseases Galveston County Health Authority UTMB COVID-19 Vaccination Preparedness Task Force Chair

    This message was sent by the Office of Marketing & Communications on behalf of the UTMB COVID-19 Vaccination Preparedness Task Force.

  • Jan. 5 COVID Task Force: UPDATED Return-to-Work/Campus Requirements for Employees, Students and Contractors

    From the COVID-19 Clinical Task Force: Antigen testing required on Day 5 for employees and students with patient care responsibilities; self-scheduling of antigen test now available for these individuals; requirements for non-health-care individuals updated. Click headline to read more.

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • Happier January - Week 1

    • Day 1 - Find three things to look forward to this year
    • Day 2 -Make time today to do something kind for yourself
    • Day 3 - Do a kind act for someone else to help to brighten their day
    • Day 4 - Write a list of things you feel grateful for and why
    • Day 5 - Look for the good in others and notice their strengths
    • Day 6 - Take five minutes to sit still and just breathe
    • Day 7 - Learn something new and share it with others
  • Dec. 28 COVID Task Force: Updated Return-On-Site Guidelines for Health Care Workers

    CDC Interim Guidelines designed to ensure adequate health care workforce during surge of omicron variant; updated return-on-site policies for UTMB health care workers take effect Dec. 28, 2021

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • Do Good December - Week 5

    • Day 22 - Congratulate someone for an achievement that may go unnoticed
    • Day 23 - Choose to give or receive the gift of forgiveness
    • Day 24 - Bring joy to others. Share something which made you laugh
    • Day 25 - Treat everyone with kindness today, including yourself!
    • Day 26 - Get outside. Do something kind for nature
    • Day 27 - Call a relative or friend who is far away to say hello and have a chat
    • Day 28 - Be kind to the planet. Consider a meatless day, recycle, bike to use less energy
    • Day 29 - Turn off digital devices and really listen to people
    • Day 30 - Let someone know how much you appreciate them and why
    • Day 31 - Plan some new acts of kindness to do in 2022
  • Dec. 17, 2021: COVID Task Force on Omicron, Boosters, Flu Vaccines

    Over the past weeks there have been new developments to the ongoing COVID-19 pandemic. A new message from the COVID-19 Clinical Task Force provides additional details on the Omicron variant, COVID boosters and flu vaccinations.

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • Do Good December - Week 3

    • Day 15 - Brighten someone’s day
    • Day 16 - Look for something positive to say to everyone you speak to
    • Day 17 - Give thanks. List the kind things others have done for you
    • Day 18 - Ask for help and let someone else discover the joy of giving
    • Day 19 - Contact someone who may be alone or feeling isolated
    • Day 20 - Help others by giving away something that you don’t need
    • Day 21 - Appreciate kindness and thank people who do things for you
  • Pfizer-BioNTech Boosters Now Available for 16+

    On Dec. 9, the U.S. Food and Drug Administration (FDA) expanded eligibility for the Pfizer-BioNTech COVID-19 booster dose to individuals 16 and 17 years of age. The Centers of Disease Control and Prevention (CDC) followed suit, recommending everyone aged 16 and older receive a booster shot.

    Adolescents 16 and 17 years old who received a Pfizer-BioNTech COVID-19 vaccine are eligible for a booster shot at least six months after completion of their primary series.

    This expansion only applies to the Pfizer-BioNTech COVID vaccine and not the Moderna or Johnson & Johnson vaccines. The mix and match of doses (e.g., receiving a Moderna primary series and a Pfizer-BioNTech booster) is not currently permitted for this age group.

    First and second doses and booster shots are available from UTMB by appointment. Schedule your COVID vaccine online.

    Additional information on the Emergency Use Authorization for the Pfizer-BioNTech vaccine is available online:

    With the emergence of the Omicron variant, getting a timely booster dose is more important than ever. Thank you for your ongoing efforts to curb the spread of disease this holiday season.

  • Do Good December - Week 2

    • Day 8 - Do something helpful for a friend or coworker
    • Day 9 -Notice when you're hard on yourself or others and be kind instead
    • Day 10 - Listen wholeheartedly to others without judging them
    • Day 11 - Buy an extra item and donate it
    • Day 12 - Be generous. Feed someone with food, love or kindness today
    • Day 13 - See how many different people you can smile at today
    • Day 14 - Share a happy memory or inspiring thought with a loved one
  • Do Good December - Week 1

    • Day 1 - Spread kindness and share the tips with others
    • Day 2 - Check in with someone to see how they are
    • Day 3 - Offer to help someone who is facing difficulties at the moment
    • Day 4 - Support a charity, cause or campaign you really care about
    • Day 5 - Give a kind word to someone who is alone for the holidays or has experienced a loss
    • Day 6 - Leave a positive message for someone else to find
    • Day 7 - Give kind comments to as many people as possible today
  • Nov. 22, 2021: Moderna, Pfizer-BioNTech COVID-19 boosters now available for all adults

    Vaccine boosters have now been approved for all adults 18 years of age and older, regardless of risk factors. Those who received a Moderna or Pfizer-BioNTech COVID-19 vaccine are eligible for a booster shot at least six months after completion of their primary series. For Johnson & Johnson/Janssen single-dose vaccine recipients, a booster is available after two months.

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • COVID-19 Boosters Now Available for All Adults

    On Nov. 19, the U.S. Food and Drug Administration (FDA) amended the emergency authorization of the Moderna and Pfizer-BioNTech vaccines, authorizing a single booster dose for all individuals age 18 years and older following the completion of the primary vaccination series with any authorized COVID vaccine. The Centers for Disease Control and Prevention subsequently issued updated booster guidance, recommending the Moderna or Pfizer-BioNTech vaccine booster for all adults, regardless of risk factors.

    Adults 18 and older who received a Moderna or Pfizer-BioNTech COVID-19 vaccine are eligible for a booster shot at least six months after completion of their primary series. Note: The Moderna COVID-19 booster dose is half of the dose administered for the primary series.

    For individuals who received the Johnson & Johnson/Janssen single-dose vaccine, a booster is recommended for everyone who was vaccinated at least two months ago, regardless of risk factors. If you have questions, please email c19vacsch@utmb.edu.

    First and second doses and booster shots are available from UTMB by appointment. Schedule your COVID vaccine online at  https://www.utmb.edu/covid-19/patients#vaccine

    Additional information on the Emergency Use Authorizations for each vaccine are available online: 

    Getting a booster dose at the recommended time can help increase protection against serious illness and hospitalization due to COVID-19. Thank you for your ongoing efforts to prevent the spread of the virus in our region.

    Schedule your Vaccine or Booster Now...

  • New Ways November - Week 4

    • Day 22 - Find a new way to tell someone you appreciate them
    • Day 23 - Set aside a regular time to pursue an activity you love
    • Day 24 - Share with a friend something helpful you learned recently
    • Day 25 - Use one of your strengths in a new or creative way
    • Day 26 - Try out a different radio station or new TV show
    • Day 27 - Join a friend doing their hobby and find out why they love it
    • Day 28 - Discover your artistic side. Design a friendly greeting card
    • Day 29 - Enjoy new music today. Play, sing, dance or listen
    • Day 30 - Look for new reasons to be hopeful, even in tough times
  • Nov. 15, 2021: COVID-19 Clinical Task Force Guidelines on Holiday Celebrations

    As departments and units across UTMB begin to plan holiday celebrations, please be mindful of the current UTMB health and safety protocols. Vaccination, masking and social distancing are still the most effective ways to protect ourselves and those around us during the holidays.

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • New Ways November - Week 3

    • Day 15 - Build on new ideas by thinking “Yes, and what if... ”
    • Day 16 - Look at life through someone else’s eyes and see their perspective
    • Day 17 - Try a new way to practice self-care and be kind to yourself
    • Day 18 - Connect with someone from a different generation
    • Day 19 - Broaden your perspective: read a different paper, magazine or site
    • Day 20 - Make a meal using a recipe or ingredient you've not tried before
    • Day 21 - Learn a new skill from a friend or share one of yours with them
  • New Ways November - Week 2

    • Day 8 - Plan a new activity or idea you want to try out this week
    • Day 9 - When you feel you can't do something, add the word "yet"
    • Day 10 - Be curious. Learn about a new topic or an inspiring idea
    • Day 11 - Choose a different route and see what you notice on the way
    • Day 12 - Find out something new about someone you care about
    • Day 13 - Do something playful outdoors - walk, run, explore, relax
    • Day 14 - Find a new way to help or support a cause you care about
  • COVID-19 Vaccine Available for Children Ages 5 to 11

    On Oct. 29, the Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in children 5 through 11 years of age. On Nov. 2, the  Centers for Disease Control and Prevention issued a recommendation that all children 5 through 11 years of age, regardless of risk factors, be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine. 

    Starting Nov. 4, all UTMB primary care locations that serve children—including pediatric clinics, family medicine clinics and urgent cares—will begin offering the vaccine, as a two-dose series at least three weeks apart. The vaccine can be administered during routine pediatric vaccination visits or can be scheduled online: https://www.utmb.edu/covid-19/patients#vaccine.

    The pediatric vaccine formulation contains one third of the adult formulation. For children who are close to age 12 when they get their first dose, a four-day grace period around their birthday is allowed to determine which dose is needed. Children who are 11 when they start the series should get another pediatric 10-microgram dose, even if they have turned 12 when they are due for their second dose.

    Pediatric clinical trials showed that the vaccine was nearly 91% effective in preventing COVID-19 among children ages 5 to 11—similar to the effectiveness seen in adult vaccine trials. In pediatric clinical trials, vaccine side effects were mild, self-limiting and similar to those seen in adults and to side effects of other vaccines recommended for children. The most common side effect was a sore arm. 

    The CDC’s new recommendation expands the COVID-19 vaccine to nearly 28 million children across the United States in this age group, marking an important step forward in our nation’s fight against the virus. Vaccinating children will help protect them from getting COVID-19 and therefore reduce their risk of severe disease, hospitalization and development of long-term COVID-19 complications. Vaccination can also help reduce disruptions to in-person learning and activities by helping to curb community transmission. 

    Additional information regarding the pediatric vaccine:

    • Written parental/guardian consent is required for vaccination of children in this age group. The parent or guardian does not need to be present during the child’s vaccination if written consent has been provided within the past 12 months and is on file with UTMB.
    • All COVID-19 vaccines may be co-administered with other vaccines, including a seasonal influenza vaccine, without any waiting period. 
    • Please consider enrolling in V-safe—CDC’s tool that provides health check-ins after someone receives a COVID-19 vaccine.

    Download information for recipients and caregivers

    Photo of Pfizer COVID Vaccine bottle
  • From the Vaccination Task Force: Pfizer-BioNTech COVID-19 vaccine now available for children ages 5 to 11

    Starting Nov. 4, all UTMB primary care locations that serve children—including pediatric clinics, family medicine clinics and urgent cares—will begin offering the vaccine, as a two-dose series at least three weeks apart. The vaccine can be administered during routine pediatric vaccination visits or can be scheduled online.

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • New Ways November - Week 1

    • Day 1 - Make a list of new things you want to do this month
    • Day 2 - Respond to a difficult situation in a different way
    • Day 3 - Get outside and observe the changes in nature around you
    • Day 4 - Sign up to join a new course, activity or online community
    • Day 5 - Change your normal routine today and notice how you feel
    • Day 6 - Try out a new way of being physically active
    • Day 7 - Be creative. Cook, draw, write, paint, make or inspire
  • Update: COVID boosters now available for Johnson & Johnson, Moderna vaccines

    On October 20, the U.S. Food and Drug Administration (FDA) made amendments to the Emergency Use Authorizations (EUA) for the Moderna and Johnson & Johnson/Janssen COVID-19 vaccines, expanding the use of a booster dose in eligible populations. On October 21, the Centers for Disease Control and Prevention issued booster recommendations for all three COVID-19 vaccines that are available in the United States. 

    The CDC has granted approval for the administration of "mix and match" vaccines—a booster different from the vaccine that was originally administered. Only one booster dose is needed regardless of which vaccine product was used for the initial/primary series.

    For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine, the following groups are eligible for a booster shot 6 months or longer after their primary series:

    Note: The Moderna COVID-19 booster dose is half of the dose administered for the primary series.

    For individuals who received the Johnson & Johnson/Janssen vaccine, a second dose is recommended for everyone who was vaccinated at least two months ago, regardless of risk factors. This vaccine is only approved for those 18 years and older. If you have questions, please email c19vacsch@utmb.edu.

    APPOINTMENTS ARE REQUIRED for all booster doses and can be made online at https://www.utmb.edu/covid-19/patients#vaccine. If you are interested in pursuing a “mix and match” option, please call (832) 632-6731 or email C19Vacsch@utmb.edu for assistance. Online scheduling for "mix and match" boosters will be available soon.

    Information on the CDC Emergency Use Authorizations for each vaccine is available online: 

     

    Thank you, 

    Janak Patel, MD
    Director, Infection Control and Healthcare Epidemiology
    Professor, Pediatrics/Infectious Disease

    Philip Keiser, MD
    Professor, Internal Medicine/Infectious Diseases
    Galveston County Health Authority
    UTMB COVID-19 Vaccination Preparedness Task Force Chair

  • COVID boosters now available for Johnson & Johnson, Moderna vaccines

    COVID-19 booster doses are now available for the Moderna and Johnson & Johnson/Janssen COVID-19 vaccines, expanding their use in eligible populations. Learn more about the recommendations for all three COVID-19 vaccines that are available in the United States.

    This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.

  • October - Week 4 (Optimistic October)

    • Day 22 - Share a hopeful quote, picture or video with a friend or colleague
    • Day 23 - Recognise that you have a choice about what to prioritise
    • Day 24 - Write down three specific things that have gone well recently
    • Day 25 - You can’t do everything! What are your three priorities this week?
    • Day 26 - Find a new perspective on a problem you face
    • Day 27 - Be kind to yourself today. Remember, progress takes time
    • Day 28 - Ask yourself, will this still matter a year from now?
    • Day 29 - Plan a fun or exciting activity to look forward to
    • Day 30 - Identify three things that give you hope for the future
    • Day 31 - Set a goal that brings a sense of purpose for the coming month
  • October - Week 3 (Optimistic October)

    • Day 15 - Thank yourself for achieving the things you often take for granted
    • Day 16 - Put down your to-do list and do something fun or uplifting
    • Day 17 - Take a small step towards a positive change you want to see in society
    • Day 18 - Set hopeful but realistic goals for the week ahead
    • Day 19 - Identify one of your positive qualities that will be helpful in the future
    • Day 20 - Find joy in tackling a task you've put off for some time
    • Day 21 - Let go of the expectations of others and focus on what matters to you